Keywords
HIV infections
Cardiovascular diseases
Acquired immunodeficiency syndrome
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the main cardiovascular manifestations in HIV patients using antiretroviral suppression therapy. Methods: Reference materials were collected by searching and selecting the Pubmed databases, the Virtual Health Library (BVS). The Health Descriptors (DECs) “cardiovascular diseases” and “HIV” were used, related to each other through the Boolean operator “AND”. As selection criteria for articles, full text available, year of publication between 2019 and 2022, language in Portuguese and English. Results: Cardiovascular manifestations in HIV-seropositive patients can be mitigated by compromising the body's immune system, supporting the inflammatory process that is proposed by metabolic alterations that affect the cardiac patient, such as dyslipidemia, peripheral insulin resistance, coagulopathies, among other manifestations that can lead to fatal consequences even in patients using antiretroviral therapy. Final considerations: Late diagnosis of the presence of HIV in patients' bodies was listed as the main limitation for therapeutic success, as well as containment of clinical complications inherent to HIV infection.
References
BITTERCOURT MS. Estimating Cardiovascular Risk in HIV-Infected Patients. Arquivos Brasileiros de Cardiologia [online], 2020; 114(1): 76-77.
FITCH KV, et al. Statins for primary cardiovascular disease prevention among people with HIV: emergent directions. Current Opinion HIV AIDS, 2022; 17(5), 293-300.
FRANCO RJS. A Atividade Física no Presente pode ser a Receita para Evitar os Males da Obesidade e Hipertensão no Futuro. Arquivos Brasileiros de Cardiologia [online], 2020; 115(1): 50-51.
BUENDIA J, et al. Prevalence and risk factors of high cholesterol and triglycerides among people with HIV in Texas. AIDS Research and Therapy, 2022; 19(1): 1-10.
DIRAJLAL-FARGO S e FUNDERBURG N. HIV and cardiovascular disease: the role of inflammation. Current Opinion HIV AIDS, 2022; 17(5): 286-292.
DELABAYS B, et al. Cardiovascular risk assessment in people living with HIV compared to the general population. European Journal of Preventive Cardiology, 2022; 29(4): 689-699.
DURSTENFELD MS, et al. Association of HIV infection with outcomes among adults hospitalized with COVID-19. AIDS, 2022; 36(3): 391-398.
GROENENDYK JW, et al. Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999-2018. Science Rep, 2021; 11(1): 1-8.
HATLEBERG CI, et al. Cardiovascular risks associated with protease inhibitors for the treatment of HIV. Expert Opinion on Drug Safety, 2021; 20(11): 1351-1366.
KNAUTH DR, et al. O diagnóstico do HIV/aids em homens heterossexuais: a surpresa permanece mesmo após mais de 30 anos de epidemia. Cadernos de Saúde Pública [online], 2020; 36(6): 1-11.
LEITE KME, et al. Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk. Arquivos Brasileiros de Cardiologia [online], 2020; 114(1): 90-97.
MANSUR AFJ. Cardiovascular Conditions of Patients on HIV Therapy. Arquivos Brasileiros de Cardiologia [online], 2020; 114(1): 98-99.
MELO ES, et al. Análise da dislipidemia em adultos vivendo com HIV. Rev Cuidarte, 2019; 10(2):1-12.
MELO ES, et al. Validação de livro eletrônico interativo para redução do risco cardiovascular em pessoas vivendo com HIV. Revista Latino-americana de Enfermagem, 2022; 30: 1-10.
PELLINI ACG, et al. AIDS em homens na cidade de São Paulo, 1980-2012: análise espacial e espaço-temporal. Revista de Saúde Pública, 2020; 54: 1-13.
PÉREZ-CHAPARRO CGA, et al. Recreational Exercising and Self-Reported Cardiometabolic Diseases in German People Living with HIV: A Cross-Sectional Study. International Journal of Environment Research and Public Health, 2021; 18(21): 1-10.
PYARALI F, et al. Cardiovascular disease and prevention among people living with HIV in South Florida. Medicine, 2021; 100(28): 1-7.
CARDINAL RMH, et al. Associative Prediction of Carotid Artery Plaques Based on Ultrasound Strain Imaging and Cardiovascular Risk Factors in People Living With HIV and Age-Matched Control Subjects of the CHACS Cohort. Journal of Acquired Immune Deficiency Syndrome, 2022; 91(1): 91-100.
SANTOS JUNIOR GG, et al. O Efeito da Atorvastatina + Aspirina na Função Endotelial Difere com a Idade em Pacientes com HIV: Um Estudo de Caso-Controle. Arquivos Brasileiros de Cardiologia [online], 2021; 117(2): 365-375.
SILVA AG, et al. Carotid Atherosclerosis and Reduced DAD Score for Cardiovascular Risk Stratification in HIV-Positive Patients. Arquivos Brasileiros de Cardiologia [online], 2020; 114(1): 68-75.
WAGLE A, et al. HIV and Global Cardiovascular Health. Current Cardio Reports, 2022; 24(9): 1149-1157.
TAN Q, et al. Exercício Físico Melhora as Funções das Células Progenitoras Endoteliais em Pacientes com Síndrome Metabólica. Arquivos Brasileiros de Cardiologia [online], 2021; 117(1): 108-117.